Gregory S Alexander
Overview
Explore the profile of Gregory S Alexander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akbari H, Bakas S, Sako C, Kazerooni A, Villanueva-Meyer J, Garcia J, et al.
Neuro Oncol
. 2024 Dec;
PMID: 39665363
Background: Glioblastoma is the most aggressive adult primary brain cancer, characterized by significant heterogeneity, posing challenges for patient management, treatment planning, and clinical trial stratification. Methods: We developed a highly...
2.
Alexander G, Krc R, Assif J, Sun K, Molitoris J, Tran P, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jun;
120(4):990-998.
PMID: 38825251
Purpose: The objective of this study was to characterize the conditional risk of developing grade 2+ urinary or gastrointestinal (GI) toxicity for patients treated with external beam radiation therapy in...
3.
Ling X, Alexander G, Molitoris J, Choi J, Schumaker L, Tran P, et al.
Front Oncol
. 2024 May;
14:1380599.
PMID: 38715772
Introduction: This study aimed to identify CT-based imaging biomarkers for locoregional recurrence (LR) in Oral Cavity Squamous Cell Carcinoma (OSCC) patients. Methods: Computed tomography scans were collected from 78 patients...
4.
Ling X, Alexander G, Molitoris J, Choi J, Schumaker L, Mehra R, et al.
Sci Rep
. 2023 Dec;
13(1):21774.
PMID: 38066047
This study addresses the limited non-invasive tools for Oral Cavity Squamous Cell Carcinoma (OSCC) survival prediction by identifying Computed Tomography (CT)-based biomarkers to improve prognosis prediction. A retrospective analysis was...
5.
Alexander G, Pollock A, Arons D, Ferris M, Molitoris J, Regine W, et al.
J Clin Imaging Sci
. 2023 Oct;
13:31.
PMID: 37810180
Objectives: Given emerging data suggesting that uncertainty in the relative biologic effectiveness at the distal end of the Bragg peak results in increased mucosal injury in patients with oropharynx cancer...
6.
Alexander G, Krc R, Assif J, Sun K, Molitoris J, Tran P, et al.
JAMA Netw Open
. 2023 Sep;
6(9):e2335069.
PMID: 37751207
Importance: As patients achieve years of survival after treatment for prostate cancer, the risk of biochemical failure (BF) or prostate cancer-specific death (PCSD) may evolve over time, with clinical relevance...
7.
Ling X, Alexander G, Molitoris J, Choi J, Schumaker L, Mehra R, et al.
Res Sq
. 2023 Sep;
PMID: 37674725
This study addresses the limited non-invasive tools for Oral Cavity Squamous Cell Carcinoma OSCC survival prediction by identifying Computed Tomography (CT)-based biomarkers for improved prognosis. A retrospective analysis was conducted...
8.
Witek M, Morris C, Alexander G, Dontu P, Koroulakis A, Regine W, et al.
Head Neck
. 2023 Mar;
45(5):1149-1155.
PMID: 36855018
Background: To evaluate disease control, toxicities, and variables associated with clinical outcomes for patients with head and neck squamous cell carcinoma and clinical N3 disease (HNSCC N3) treated with definitive...
9.
Pollock A, Arons D, Alexander G, Alicia D, Birkman K, Molitoris J, et al.
Head Neck
. 2023 Feb;
45(5):1088-1096.
PMID: 36840723
Background: To determine if the extent of high-dose gross tumor volume (GTV) to clinical target volume (CTV) expansion is associated with local control in patients with p16-positive oropharynx cancer (p16+ ...
10.
Pati S, Baid U, Edwards B, Sheller M, Wang S, Reina G, et al.
Nat Commun
. 2023 Jan;
14(1):436.
PMID: 36702828
No abstract available.